Perrigo Debuts On US National Brand Stage With OTC Switch Approval For Nasonex 24HR Allergy

Nasonex 24HR Allergy also will be first OTC mometasone furoate product available in US. It will compete in OTC intranasal corticosteroids category already led by other brands switched from Rx to nonprescription over past eight years.